Trial Profile
Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Aug 2012
Price :
$35
*
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Postoperative infections
- Focus Pharmacokinetics
- Sponsors Basilea Pharmaceutica
- 27 Jul 2012 Actual initiation date changed from 1 May 2009 to 1 Apr 2009 as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Company (Basilea Pharmaceutica) added as an association and lead centre as reported by ClinicalTrials.gov record.
- 31 Mar 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.